Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapse

MLA

Henry de Traux de Wardin, et al. “Sequential Genomic Analysis Using a Multisample/Multiplatform Approach to Better Define Rhabdomyosarcoma Progression and Relapse.” Npj Precision Oncology, vol. 7, no. 1, Sept. 2023, pp. 1–13. EBSCOhost, https://doi.org/10.1038/s41698-023-00445-1.

APA

Henry de Traux de Wardin, Josephine K. Dermawan, Marie-Sophie Merlin, Leonard H. Wexler, Daniel Orbach, Fabio Vanoli, Gudrun Schleiermacher, Birgit Geoerger, Stelly Ballet, Delphine Guillemot, Eléonore Frouin, Stacy Cyrille, Olivier Delattre, Gaelle Pierron, & Cristina R. Antonescu. (2023). Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapse. Npj Precision Oncology, 7(1), 1–13. https://doi.org/10.1038/s41698-023-00445-1

Chicago

Henry de Traux de Wardin, Josephine K. Dermawan, Marie-Sophie Merlin, Leonard H. Wexler, Daniel Orbach, Fabio Vanoli, Gudrun Schleiermacher, et al. 2023. “Sequential Genomic Analysis Using a Multisample/Multiplatform Approach to Better Define Rhabdomyosarcoma Progression and Relapse.” Npj Precision Oncology 7 (1): 1–13. doi:10.1038/s41698-023-00445-1.